Viewing Study NCT00634751


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-01-01 @ 1:43 PM
Study NCT ID: NCT00634751
Status: COMPLETED
Last Update Posted: 2019-11-26
First Post: 2008-03-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
Sponsor: University of Wisconsin, Madison
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Neoplasms View
None Bile Duct Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced pancreatic and biliary tract carcinomas View